These observations, and the recent appreciation that p53 promotes a metabolic program that results in increased levels of cellular anti-oxidants [78], raise the concern that in specific pathological contexts, p53 may be exploited by cancer cells in order increase anti-oxidants to gain chemo resistance, much like NRF2. Here, TP53 is linked to cancer.